Current Drug Targets
Title:Editorial
Volume: 20 Issue: 2
Author(s): Ahmad Hatim Sulaiman and Ramli Musa
Affiliation:
Export Options
About this article
Cite this article as:
Sulaiman Hatim Ahmad and Musa Ramli , Editorial, Current Drug Targets 2019; 20 (2) . https://dx.doi.org/10.2174/138945012002181203145147
DOI https://dx.doi.org/10.2174/138945012002181203145147 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ex Vivo Gene Therapy and Vision
Current Gene Therapy Nanoparticles in the Treatment of Mental Disorders: A New Tool in the Psychiatric Medication
Current Topics in Medicinal Chemistry Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Therapeutic Approaches Targeting Pathological Tau Aggregates
Current Pharmaceutical Design 3D-QSAR of Novel Phosphodiesterase-4 Inhibitors by Genetic Function Approximation
Medicinal Chemistry Contingency Management for Smoking Cessation: Where Do We Go from Here?
Current Drug Abuse Reviews Arrest of Amyloid Fibril Formation Associated to Type II Diabetes: Structural and Functional Links to the Mechanism of Alzheimers β- Amyloid Fibrillization
Drug Design Reviews - Online (Discontinued) Carbon-11 Labeled Tracers for In Vivo Imaging of P-Glycoprotein Function: Kinetics, Advantages and Disadvantages
Current Topics in Medicinal Chemistry High Content Screening for G Protein-Coupled Receptors Using Cell-Based Protein Translocation Assays
Combinatorial Chemistry & High Throughput Screening Importance of Zebrafish as an Efficient Research Model for the Screening of Novel Therapeutics in Neurological Disorders
CNS & Neurological Disorders - Drug Targets MicroRNAs: Newcomers into the ALS Picture
CNS & Neurological Disorders - Drug Targets Acknowledgements to Reviewers
CNS & Neurological Disorders - Drug Targets Forecasting Roles of Combinatorial Chemistry in the Age of Genomically Derived Drug Discovery Targets
Combinatorial Chemistry & High Throughput Screening Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Anti-Cancer Agents in Medicinal Chemistry Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
Current Pharmaceutical Design Hippocampal-Dependent Inhibitory Learning and Memory Processes in the Control of Eating and Drug Taking
Current Pharmaceutical Design Editorial (Thematic Issue: Linkage of CNS and Immunology with Psychology: Searching for New Pharmacological Targets)
CNS & Neurological Disorders - Drug Targets Membrane Damage Induced by Amyloid Beta and a Potential Link with Neuroinflammation
Current Pharmaceutical Design 5-HT1 Receptors
Current Drug Targets - CNS & Neurological Disorders GPR40 Carboxylic Acid Receptor Family and Diabetes: A New Drug Target
Current Drug Targets